, representing an increase from the previous year by Baht 270 Million or 0.7 percent when compared to the end of the year 2019 mainly from the net profit from operation, unrealized gain on fair value adjustment of
company have also completed a Mandatory Tender Offer from GLOW which ended on the 22nd May 2019 of 26.14%, which has resulted in the company being able to recognize net profit for the company at 95.25
2019 of 26.14%, has resulted in the company being able to recognize net profit for the company at 95.25% after the 22nd May 2019. Consequently, on the 19th June 2019, the Board of Directors has passed
until the gross profit being reported differently from the previous periods Operating Highlights in Q4/2019 & 2019 Q4/18 Q3/19 Q4/19 Change +/(-) 2018 2019 Change+/(-) (Unit: Million Baht) QoQ YoY
, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 9. Expected Benefits for the Company: The company expects to benefit from the opportunity of being more competitive
%. This was due to expenses relating to the initial public offering being tax deductible. Net Profit For the three months ending 31 March of 2018 and 2019, the net profit increased from THB 24.1 Mn to THB
acquired businesses/ assets is a combination of business and assets carved out from the Seller’s total businesses. 2. The net profits (Net operating profit of the assets/ business being acquired) X
company has changed the classification of operating income and cost of sales resulting in the operating income until the gross profit being reported differently from the previous periods 2. From Q1/2020
from operating activities was THB 1,208mn. This was derived from profit before tax of THB 1,968mn, being offset by non-cash reconciling items of THB 602mn and changes in net working capital of THB 158mn
, significantly increasing from the same period last year due to higher operating EBITDA, as a result of hotel business expansion and gain from exchange rates • Reported net profit of THB 393mn (compared to a net